当前位置: 首页 > 期刊 > 《世界华人消化杂志》 > 2007年第1期
编号:11359273
缬草波春诱导MKN-45胃癌细胞凋亡
http://www.100md.com 叶建明, 胡品津, 易粹琼, 薛存宽, 呼闯营, 陈凤鸣, 钱 伟
缬草波春;细胞凋亡;半胱氨酸酶抑制剂;生存素;P53,叶建明,胡品津,易粹琼,呼闯营,陈凤鸣,钱伟,薛存宽,叶建明,通讯作者:,Valepotriate-inducedapoptosisofgastriccancercelllineMKN-4
第3页
第1页

    参见附件(1042KB,7页)。

     叶建明, 中山大学博士后流动站, 中山市人民医院消化内科 广东省中山市 528402

    胡品津,
中山大学附属第一医院消化内科 广东省广州市 510080

    易粹琼, 呼闯营, 陈凤鸣, 钱伟,
华中科技大学同济医学院附属协和医院消化科 湖北省武汉市 430020

    薛存宽,
华中科技大学同济医学院老年医学研究所 湖北省武汉市 430077

    叶建明,
医学博士, 副主任医师, 2004年中山大学博士后流动站进站博士, 主要从事消化系统肿瘤研究.

    通讯作者:
叶建明, 528402, 广东省中山市石岐区孙文中路2号, 中山市人民医院消化内科. yjm3839@sina.com

    电话: 0760-8840528

    收稿日期: 2006-08-08 接受日期: 2006-10-18

    Valepotriate-induced apoptosis of gastric cancer cell line MKN-45

    
Jian-Ming Ye, Pin-Jin Hu, Cui-Qiong Yi, Cun-Kuan Xue, Chuang-Ying Hu, Feng-Ming Chen, Wei Qian

    Jian-Ming Ye,
Postdoctoral Station of Sun Yat-Sen University; Department of Gastroenterology, Zhongshan People's Hospital, Zhongshan 528402, Guangdong Province, China

    Pin-Jin Hu,
Department of Gastroenterology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, Guangdong Province, China

    Cui-Qiong Yi, Chuang-Ying Hu, Feng-Ming Chen, Wei Qian,
Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430020, Hubei Province, China

    Cun-Kuan Xue,
Institution of Geriatric Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430077, Hubei Province, China

    Correspondence to:
Jian-Ming Ye, Postdoctoral Station of Sun Yat-Sen University; Department of Gastroenterology, Zhongshan People's Hospital, Zhongshan 528402, Guangdong Province, China. yjm3839@sina.com

    Received:
2006-08-08 Accepted:2006-10-18

    Abstract

    AIM: To study the apoptosis of gastric cancer cell line MKN-45 induced by valepotriate and its relationship with the expression of Caspase, P53, and Survivin.

    METHODS: Gastric cancer cell line MKN-45 was divided into 4 groups, named group A (control), B (treated with Caspase-3, -8 and -9 inhibitors), C (treated with valepotriate) and D (treated with inhibitory agents plus valepotriate), respectively ......

您现在查看是摘要介绍页,详见PDF附件(1042KB,7页)